论文部分内容阅读
目的探讨解痉降压药物配合生活指导治疗妊娠期高血压的疗效。方法将妊娠期高血压患者220例随机分为研究组和对照组各110例。2组均根据妊娠期高血压常规治疗原则给予硫酸镁、硝苯地平等解痉降压等药物治疗和常规住院护理。研究组另给予妊娠期高血压疾病健康教育、科学营养指导、孕期健康锻炼等生活指导。分别于治疗前和分娩前1周检测2组患者血压水平,观察2组妊娠期高血压相关疾病发生率及治疗效果。结果治疗前2组患者收缩压和舒张压水平差异均无统计学意义(P>0.05)。治疗后2组患者收缩压和舒张压均低于治疗前,且研究组明显低于对照组,差异均有统计学意义(P<0.05)。研究组发生妊娠期高血压相关疾病10例(9.09%),而对照组高达31例(28.18%),差异有统计学意义(P<0.05)。试验组的总有效率为96.36%高于对照组的28.18%,差异有统计学意义(P<0.05)。结论解痉降压药物配合生活指导治疗妊娠期高血压具有良好的治疗效果,可有效降低妊娠期孕妇血压和相关疾病发生。
Objective To investigate the effect of antispasmodic antihypertensive drugs with life guidance in the treatment of gestational hypertension. Methods 220 patients with gestational hypertension were randomly divided into study group and control group of 110 cases. Both groups were given magnesium sulfate and nifedipine antispasmodic and antihypertensive drugs and routine hospitalization according to the principle of routine treatment of hypertension during pregnancy. In addition, the study group gave life guidance on gestational hypertension disease health education, scientific nutrition guidance and pregnant healthy exercise. Blood pressure was measured before treatment and 1 week before delivery, respectively. The incidence of hypertension-related diseases in pregnancy and the therapeutic effect were observed. Results There was no significant difference in systolic blood pressure and diastolic blood pressure between the two groups before treatment (P> 0.05). The systolic and diastolic blood pressure of the two groups after treatment were lower than those before treatment, and the study group was significantly lower than the control group, the difference was statistically significant (P <0.05). There were 10 cases (9.09%) of pregnancy-related hypertension related diseases in the study group, and 31 cases (28.18%) in the control group, the difference was statistically significant (P <0.05). The total effective rate of the experimental group was 96.36% higher than that of the control group (28.18%), the difference was statistically significant (P <0.05). Conclusion Anti-spasm and antihypertensive drugs with life guidance for the treatment of gestational hypertension has a good therapeutic effect, which can effectively reduce the incidence of gestational blood pressure and related diseases in pregnant women.